Invitrogen has announced the launch of its Omnia kinase assays for the rapid, homogenous and sensitive detection of enzymatic activity under physiological ATP concentrations.
Scientists can simply mix reagents, read real-time fluorescent signals and get results in under an hour.
Omnia offers a simple mix and read procedure, streamlining assay set-up and speeding data collection.
